Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$2,743,765
in 2 filings
Open-market sales, last 90 days
$1,708,041
in 8 filings, $650K under 10b5-1 plans

Net +$1,035,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 Hasnain Faheem Director Grant or award · Option to purchase common stock +35,000 35,000
2025-12-09 Hasnain Faheem Director Option exercise +10,000 $3.12 $31K 33,983
2025-12-09 Hasnain Faheem Director Sale −10,000 $10.98 $110K 23,983
2025-06-05 Hasnain Faheem Director Grant or award · Option to purchase common stock +28,500 28,500
2025-03-21 Hasnain Faheem Director Option exercise +22,682 $6.32 $143K 46,665
2025-03-21 Hasnain Faheem Director Sale −22,682 $8.00 $181K 23,983
2024-06-05 Hasnain Faheem Director Grant or award · Option to purchase common stock +26,000 26,000

Page 1 of 1 · 7 trades